Bladder Regeneration is a pioneering area in regenerative medicine that aims to restore or replace damaged bladder tissues, addressing conditions such as bladder dysfunction, trauma, or congenital anomalies. Traditional treatments often involve surgical interventions or tissue grafts, but bladder regeneration seeks to provide more sophisticated and long-lasting solutions. Biotechnological approaches in bladder regeneration involve the use of stem cells, biomaterials, and tissue engineering strategies. Stem cells, including mesenchymal stem cells or induced pluripotent stem cells, are employed to differentiate into specific bladder cell types, fostering tissue repair and regeneration. Biomaterials such as biodegradable scaffolds or matrices play a crucial role in providing structural support and promoting cell attachment and growth. These scaffolds can be designed to mimic the native extracellular matrix, enhancing the integration of regenerated tissues with the existing bladder. Bladder regeneration also explores the use of growth factors and signaling molecules to stimulate cell proliferation and differentiation. Advances in gene therapy enable the targeted delivery of therapeutic genes, influencing cellular functions critical for tissue repair. Clinical trials and research studies on bladder regeneration are ongoing, exploring the safety, efficacy, and long-term outcomes of these innovative approaches. Challenges include achieving functional and durable tissue regeneration and ensuring compatibility with the complex physiological environment of the bladder. The development of successful bladder regeneration strategies holds great promise for improving the quality of life for individuals with bladder-related disorders and advancing the field of regenerative medicine.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy